Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Radlmaier

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Progress in Clinical and Biological Research|January 1, 1989
Hot flushes: mechanism and preventionA Radlmaier, F Neumann, K Bormacher
Progress in Clinical and Biological Research|January 1, 1989
Differences in action and toxicity of antiandrogensF Neumann, K Bormacher, A Radlmaier
Progress in Clinical and Biological Research|January 1, 1990
Hot flushes: mechanism and preventionA Radlmaier, K Bormacher, F Neumann
Progress in Clinical and Biological Research|January 1, 1990
Principles of androgen deprivationF Neumann, K Bormacher, U F Habenicht, et al.
Journal of Clinical Pharmacy and Therapeutics|September 28, 2016
Fixed-dose combination of nifedipine gastrointestinal therapeutic system and candesartan cilexetil in patients with moderate-to-severe essential hypertension: an open-label, long-term safety and efficacy studyS E Kjeldsen, P Dzongowski, N Li, et al.
The Prostate|October 1, 1996
Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study GroupA Radlmaier, H U Eickenberg, M S Fletcher, et al.
Human Reproduction (Oxford, England)|October 28, 2006
Miglustat has no apparent effect on spermatogenesis in normal menJ K Amory, C H Muller, S T Page, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Progress in Clinical and Biological Research|January 1, 1989
Hot flushes: mechanism and preventionA Radlmaier, F Neumann, K Bormacher
Progress in Clinical and Biological Research|January 1, 1989
Differences in action and toxicity of antiandrogensF Neumann, K Bormacher, A Radlmaier
Progress in Clinical and Biological Research|January 1, 1990
Hot flushes: mechanism and preventionA Radlmaier, K Bormacher, F Neumann
Progress in Clinical and Biological Research|January 1, 1990
Principles of androgen deprivationF Neumann, K Bormacher, U F Habenicht, et al.
Journal of Clinical Pharmacy and Therapeutics|September 28, 2016
Fixed-dose combination of nifedipine gastrointestinal therapeutic system and candesartan cilexetil in patients with moderate-to-severe essential hypertension: an open-label, long-term safety and efficacy studyS E Kjeldsen, P Dzongowski, N Li, et al.
The Prostate|October 1, 1996
Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study GroupA Radlmaier, H U Eickenberg, M S Fletcher, et al.
Human Reproduction (Oxford, England)|October 28, 2006
Miglustat has no apparent effect on spermatogenesis in normal menJ K Amory, C H Muller, S T Page, et al.
Pageof 1